<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Male Urethritis – One‑Page Reference Algorithm (NICE CKS May 2024)</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=JetBrains+Mono:wght@500&display=swap" rel="stylesheet">
  <style>
    :root {
      --bg: #0b0c10;
      --panel: #0f1117;
      --ink: #e9eef8;
      --muted-ink: #b6bed2;
      --brand: #7c9cff;
      --accent: #46e6b0;
      --warn: #ffd166;
      --danger: #ff6b6b;
      --ok: #5ee28b;
      --ring: #7c9cff55;
      --card: linear-gradient(180deg, #111317, #0d0f14);
      --shadow: 0 1px 0 rgba(255,255,255,0.02) inset, 0 20px 40px -20px rgba(0,0,0,0.6);
    }
    :root.light {
      --bg: #f6f7fb;
      --panel: #ffffff;
      --ink: #0e1320;
      --muted-ink: #4b5566;
      --brand: #335cff;
      --accent: #12b886;
      --warn: #f2c94c;
      --danger: #ef476f;
      --ok: #2ecc71;
      --ring: #335cff33;
      --card: linear-gradient(180deg, #ffffff, #fbfbfe);
      --shadow: 0 1px 0 rgba(0,0,0,0.04) inset, 0 12px 30px -12px rgba(13,18,30,0.25);
    }

    * { box-sizing: border-box; }
    html, body { height: 100%; }
    body {
      margin: 0;
      background: radial-gradient(1200px 800px at 10% -10%, #1a1f2b44, transparent),
                  radial-gradient(1200px 800px at 110% -20%, #0e334444, transparent),
                  var(--bg);
      color: var(--ink);
      font-family: Inter, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      line-height: 1.55;
    }

    .container { max-width: 1100px; margin: 0 auto; padding: 24px; }

    header.navbar {
      position: sticky; top: 0; z-index: 20;
      background: rgba(255,255,255,0.02);
      backdrop-filter: blur(8px);
      border-bottom: 1px solid rgba(124,156,255,0.15);
    }
    header .bar { display:flex; align-items:center; gap:16px; padding: 14px 24px; }
    header h1 { font-size: clamp(18px, 3.5vw, 24px); margin: 0; letter-spacing: 0.2px; }
    .badge { display:inline-flex; align-items:center; gap:8px; font-size:12px; padding: 6px 10px; border-radius: 999px; border: 1px solid var(--ring); background: linear-gradient(180deg, rgba(124,156,255,0.12), rgba(124,156,255,0.03)); color: var(--ink); }
    .spacer { flex:1; }
    .btn {
      appearance: none; border: 1px solid transparent; background: var(--panel); color: var(--ink);
      padding: 10px 12px; border-radius: 12px; cursor: pointer; font-weight: 600; 
      box-shadow: var(--shadow); display:inline-flex; align-items:center; gap:10px;
    }
    .btn:hover { border-color: var(--ring); box-shadow: 0 0 0 4px var(--ring), var(--shadow); }
    .btn-ghost { background: transparent; border-color: var(--ring); }

    .hero {
      display:grid; grid-template-columns: 1.1fr 0.9fr; gap: 24px; align-items: center; padding: 32px 0 12px;
    }
    .hero h2 { font-size: clamp(24px, 4.5vw, 42px); line-height:1.15; margin: 0 0 10px; }
    .hero p { margin: 0; color: var(--muted-ink); }
    .pillset { display:flex; flex-wrap:wrap; gap:10px; margin-top:16px; }
    .pill { border:1px dashed var(--ring); padding:8px 10px; border-radius: 10px; font-size: 12px; color: var(--muted-ink); }

    .grid { display:grid; grid-template-columns: repeat(12, 1fr); gap: 16px; }

    .card {
      grid-column: span 12;
      background: var(--card);
      border-radius: 18px;
      border: 1px solid rgba(124,156,255,0.18);
      box-shadow: var(--shadow);
      padding: 18px 18px 16px;
      position: relative;
      overflow: clip;
    }
    .card h3 { margin: 0 0 10px; font-size: clamp(16px, 2.5vw, 20px); }
    .card h4 { margin: 10px 0 6px; font-size: 14px; letter-spacing: 0.2px; color: var(--muted-ink); text-transform: uppercase; }

    .cols-2 { columns: 2; column-gap: 24px; }
    .cols-3 { columns: 3; column-gap: 24px; }

    ul.tight { margin: 0; padding-left: 18px; }
    ul.tight li { margin: 6px 0; }

    .accent-bar { position:absolute; inset:0 auto auto 0; width: 4px; height: 100%; background: linear-gradient(180deg, var(--brand), var(--accent)); }

    .kpi { display:flex; gap: 10px; flex-wrap: wrap; margin-top: 10px; }
    .chip { display:inline-flex; align-items:center; gap:8px; font-size: 12px; border:1px solid var(--ring); border-radius: 999px; padding: 6px 10px; }
    .chip .dot { width:8px; height:8px; border-radius: 99px; background: var(--accent); box-shadow: 0 0 0 3px #46e6b022; }
    .chip.warn .dot { background: var(--warn); box-shadow: 0 0 0 3px #ffd16622; }
    .chip.danger .dot { background: var(--danger); box-shadow: 0 0 0 3px #ff6b6b22; }

    .flow { display:grid; grid-template-columns: repeat(12, 1fr); gap: 12px; }
    .step { grid-column: span 12; border:1px solid var(--ring); border-radius: 14px; padding: 12px; }
    .step h5 { margin: 0 0 6px; font-size: 14px; }

    .two-col { display:grid; grid-template-columns: 1fr 1fr; gap: 12px; }

    .table { width: 100%; border-collapse: collapse; margin-top: 8px; font-size: 14px; }
    .table th, .table td { text-align:left; padding: 8px 10px; border-bottom: 1px dashed rgba(124,156,255,0.25); vertical-align: top; }
    .table th { font-weight: 600; color: var(--muted-ink); text-transform: uppercase; font-size: 12px; letter-spacing: 0.4px; }

    details { border:1px solid var(--ring); border-radius: 12px; padding: 10px 12px; }
    details summary { list-style:none; cursor: pointer; font-weight: 600; }
    details[open] { box-shadow: 0 0 0 4px var(--ring); }

    .footer { color: var(--muted-ink); display:flex; flex-wrap:wrap; align-items:center; gap: 12px; justify-content: space-between; margin: 22px 0 8px; }

    .floating {
      position: fixed; right: 18px; bottom: 18px; z-index: 30;
      display:flex; gap:10px; flex-direction:column;
    }

    .sr-only { position:absolute; width:1px; height:1px; padding:0; margin:-1px; overflow:hidden; clip:rect(0,0,0,0); white-space:nowrap; border:0; }

    @media (min-width: 820px) {
      .card.span-6 { grid-column: span 6; }
      .card.span-4 { grid-column: span 4; }
      .card.span-8 { grid-column: span 8; }
    }
    @media print {
      :root { --bg: #ffffff; --panel:#fff; --ink:#000; --muted-ink:#333; --ring:#00000022; --brand:#000; --accent:#000; }
      body { background: #fff; }
      header.navbar, .floating { display:none !important; }
      .container { padding: 0; }
      .card { break-inside: avoid; border-color: #00000033; box-shadow: none; background: #fff; }
      .accent-bar { display:none; }
      a { color: #000; text-decoration: none; }
    }
  </style>
</head>
<body>
  <a class="sr-only" href="#content">Skip to content</a>
  <header class="navbar">
    <div class="bar container">
      <h1>Male Urethritis — One‑Page Reference</h1>
      <span class="badge" title="Last revised May 2024">NICE CKS • May 2024</span>
      <div class="spacer"></div>
      <button class="btn" id="themeToggle" aria-pressed="false" title="Toggle light/dark">
        <svg width="16" height="16" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M12 3a1 1 0 0 1 1 1v1a1 1 0 1 1-2 0V4a1 1 0 0 1 1-1Zm0 15a5 5 0 1 0 0-10 5 5 0 0 0 0 10Zm7-5a1 1 0 0 1 1 1h1a1 1 0 1 1 0 2h-1a1 1 0 1 1 0-2h1a1 1 0 1 1 0-2h-1a1 1 0 1 1-2 0 1 1 0 0 1 1-1Zm-7 7a1 1 0 0 1 1 1v1a1 1 0 1 1-2 0v-1a1 1 0 0 1 1-1ZM4 11a1 1 0 0 1 1 1H4a1 1 0 1 1 0-2h1a1 1 0 1 1 0 2H4Zm1.64-6.64a1 1 0 0 1 1.41 0l.71.7a1 1 0 1 1-1.41 1.42l-.71-.71a1 1 0 0 1 0-1.41Zm0 13.28a1 1 0 0 1 1.41 0l.71.71a1 1 0 1 1-1.41 1.41l-.71-.7a1 1 0 0 1 0-1.42Zm12.72-12.72a1 1 0 0 1 0 1.41l-.71.71a1 1 0 1 1-1.41-1.41l.71-.71a1 1 0 0 1 1.41 0Zm0 12.72a1 1 0 0 1 0 1.41l-.71.7a1 1 0 1 1-1.41-1.41l.71-.71a1 1 0 0 1 1.41 0Z" fill="currentColor"/></svg>
        Theme
      </button>
      <button class="btn btn-ghost" onclick="window.print()" title="Print or save to PDF">
        <svg width="16" height="16" viewBox="0 0 24 24" fill="none" aria-hidden="true"><path d="M6 9V3h12v6M6 17H4a2 2 0 0 1-2-2v-3a2 2 0 0 1 2-2h16a2 2 0 0 1 2 2v3a2 2 0 0 1-2 2h-2m-2 4H8a2 2 0 0 1-2-2v-5h12v5a2 2 0 0 1-2 2Z" stroke="currentColor" stroke-width="1.6" stroke-linecap="round" stroke-linejoin="round"/></svg>
        Print
      </button>
    </div>
  </header>

  <main id="content" class="container">
    <section class="hero">
      <div>
        <h2>Fast decision‑support for consultations</h2>
        <p>Concise, clinic‑ready algorithm covering assessment, empiric therapy, follow‑up and treatment failure for men ≥16 years.</p>
        <div class="pillset">
          <span class="pill">Primary feature: urethral discharge ± dysuria</span>
          <span class="pill">Test broadly (NAATs + BBV screen)</span>
          <span class="pill">Refer to GUM when possible</span>
          <span class="pill">Empiric doxycycline first‑line</span>
        </div>
        <div class="kpi">
          <span class="chip"><span class="dot"></span> One‑page layout</span>
          <span class="chip warn"><span class="dot"></span> Fluoroquinolone caution (MHRA)</span>
          <span class="chip"><span class="dot"></span> Print‑friendly</span>
        </div>
      </div>
      <div>
        <div class="card" role="note" aria-label="Bottom line">
          <div class="accent-bar" aria-hidden="true"></div>
          <h3>Bottom line</h3>
          <ul class="tight">
            <li><strong>Refer to GUM</strong> where possible for confirmation and management.</li>
            <li>If managed in primary care, <strong>doxycycline 100 mg PO BD × 7 days</strong> is first‑line for NGU.</li>
            <li>Advise <strong>no sex</strong> until both patient and partners complete treatment and symptoms resolve.</li>
            <li><strong>Review at 1–2 weeks:</strong> symptom resolution, results, and partner notification.</li>
          </ul>
        </div>
      </div>
    </section>

    <section class="grid" aria-label="Algorithm">
      <!-- Clinical suspicion -->
      <article class="card span-6">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>1) Clinical suspicion</h3>
        <ul class="tight">
          <li>Urethral discharge (mucoid / mucopurulent / purulent) — may be minimal; may need urethral milking.</li>
          <li>Dysuria; ± penile irritation/erythema, itch, balanoposthitis.</li>
        </ul>
      </article>

      <!-- Assessment -->
      <article class="card span-6">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>2) Assessment</h3>
        <div class="two-col">
          <div>
            <h4>History</h4>
            <ul class="tight">
              <li>Symptoms, onset, last sexual contact (and previous if ≤3 months), partners and numbers.</li>
              <li>Type of sex/sites exposed; condom use; risk behaviours; prior STIs; BBV risks; trauma/irritants; PMH; drugs; allergies.</li>
            </ul>
          </div>
          <div>
            <h4>Examination</h4>
            <ul class="tight">
              <li>Underwear for discharge; genital exam; retract foreskin; assess meatus for discharge/crusting/redness.</li>
              <li>If no discharge, gently milk urethra. Palpate for adenopathy, masses, tenderness. ± DRE if prostatitis suspected.</li>
            </ul>
          </div>
        </div>
        <h4>Investigations</h4>
        <ul class="tight">
          <li>First‑void urine NAAT: <em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em> (same sample if local lab supports).</li>
          <li>Consider: <em>Mycoplasma genitalium</em> NAAT (local availability); <em>Trichomonas</em> (urethral swab and/or first‑void urine) if suspected/partner positive.</li>
          <li>Screen: HIV, syphilis ± hepatitis (risk‑based). If UTI suspected → MSU for C&S.</li>
        </ul>
        <h4>Working diagnosis in primary care if any:</h4>
        <ul class="tight">
          <li>Mucopurulent/purulent discharge; or</li>
          <li>First‑void urine leukocyte esterase ≥1+ (collect ≥1 h after last void); or</li>
          <li>Urinary threads (mucus/pus strands) in first‑void urine (note: may be physiological).</li>
        </ul>
      </article>

      <!-- Management -->
      <article class="card span-8">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>3) Management</h3>
        <div class="flow">
          <div class="step">
            <h5>Refer</h5>
            <p>Offer <strong>GUM referral</strong> to all for confirmation and treatment. If declined or not possible → manage in primary care.</p>
          </div>
          <div class="step">
            <h5>Empiric treatment for suspected <abbr title="Non‑gonococcal urethritis">NGU</abbr></h5>
            <table class="table" aria-label="Empiric regimens">
              <thead>
                <tr><th>Regimen</th><th>Dose &amp; Duration</th><th>Notes</th></tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Doxycycline</strong> (first‑line)</td>
                  <td>100 mg PO <abbr title="twice daily">BD</abbr> × 7 days</td>
                  <td>Check contraindications (pregnancy, breastfeeding, <12 y), photosensitivity advice.</td>
                </tr>
                <tr>
                  <td><strong>Azithromycin</strong> (alternative)</td>
                  <td>1 g stat → 500 mg PO <abbr title="once daily">OD</abbr> × 2 days</td>
                  <td>Abstain from sex until <strong>14 days after start</strong> and symptoms resolve; QT‑risk cautions.</td>
                </tr>
                <tr>
                  <td><strong>Ofloxacin</strong> (alternative if others unsuitable)</td>
                  <td>200 mg <abbr title="twice daily">BD</abbr> or 400 mg <abbr title="once daily">OD</abbr> × 7 days</td>
                  <td><strong>Fluoroquinolone safety:</strong> use only if necessary (MHRA). Tendon/CNS/QT/aorta/valve cautions.</td>
                </tr>
              </tbody>
            </table>
          </div>
          <div class="step">
            <h5>If specific organism suspected</h5>
            <ul class="tight">
              <li><strong>Gonorrhoea</strong> suspected (e.g., local outbreak) → treat per gonorrhoea guideline.</li>
              <li><strong>Trichomonas</strong> suspected/partner positive → treat per trichomonas guideline.</li>
            </ul>
          </div>
          <div class="step">
            <h5>Advice &amp; partner management</h5>
            <ul class="tight">
              <li>Likely STI cause; discuss complications for patient/partners.</li>
              <li><strong>No sexual contact</strong> (incl. oral) until patient <em>and</em> partners complete treatment and symptoms resolve.</li>
              <li>Adherence and adverse‑effect counselling; safer‑sex/condom use; provide BASHH/FPA leaflets.</li>
              <li><strong>Partner notification:</strong> all partners in previous <strong>4 weeks</strong> (follow specific STI guidance if positive).</li>
            </ul>
          </div>
        </div>
      </article>

      <!-- Follow-up -->
      <article class="card span-4">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>4) Follow‑up (1–2 weeks)</h3>
        <ul class="tight">
          <li>Check symptom resolution; review lab results.</li>
          <li>Ensure partner notification completed.</li>
          <li>Address adherence/adverse effects; reinforce safer sex.</li>
        </ul>
      </article>

      <!-- Treatment failure -->
      <article class="card span-12">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>5) Treatment failure (persistent/recurrent symptoms)</h3>
        <div class="two-col">
          <div>
            <h4>First steps</h4>
            <ul class="tight">
              <li>Strongly re‑offer <strong>GUM attendance</strong>.</li>
              <li>Check <strong>adherence</strong> and exclude <strong>re‑infection</strong> (partners treated simultaneously?).</li>
              <li>Reconsider diagnosis (UTI, prostatitis, HSV, balanitis, stones, reactive arthritis, non‑infective causes).</li>
            </ul>
          </div>
          <div>
            <h4>Second‑line regimens</h4>
            <table class="table" aria-label="Second line regimens">
              <thead>
                <tr><th>After first‑line</th><th>Next step</th><th>Important notes</th></tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Doxycycline</strong></td>
                  <td><strong>Azithromycin</strong> 1 g stat → 500 mg OD × 2 days <br> <strong>+</strong> <strong>Metronidazole</strong> 400 mg BD × 5 days</td>
                  <td>Start azithro within <strong>2 weeks</strong> of finishing doxycycline. Abstain from sex until <strong>14 days after start</strong> and symptoms resolve.</td>
                </tr>
                <tr>
                  <td><strong>Azithromycin</strong></td>
                  <td><strong>Moxifloxacin</strong> 400 mg OD × 10 days <br> <strong>+</strong> <strong>Metronidazole</strong> 400 mg BD × 5 days</td>
                  <td>Alternatively consider <strong>Doxycycline</strong> 100 mg BD × 7 days + <strong>Metronidazole</strong> 400 mg BD × 5 days if <em>M. genitalium</em> not tested/confirmed.</td>
                </tr>
              </tbody>
            </table>
            <p style="margin-top:8px">If symptoms persist despite a second course → <strong>seek specialist advice</strong>.</p>
          </div>
        </div>
      </article>

      <!-- Useful extras -->
      <article class="card span-12">
        <div class="accent-bar" aria-hidden="true"></div>
        <h3>Quick safety notes</h3>
        <div class="cols-3">
          <div>
            <h4>Doxycycline</h4>
            <ul class="tight">
              <li>Avoid in pregnancy, breastfeeding, and children &lt;12 y.</li>
              <li>Photosensitivity; oesophagitis risk (take with water, sit upright).</li>
              <li>Interactions: antacids/iron/zinc (separate 2–3 h), warfarin (↑INR), retinoids (avoid), lithium/carbamazepine/phenytoin (monitor).</li>
            </ul>
          </div>
          <div>
            <h4>Azithromycin</h4>
            <ul class="tight">
              <li>QT‑prolongation risk; caution with other QT‑drugs/electrolyte issues.</li>
              <li>Interactions: digoxin/warfarin/statins/rifabutin/DOACs (monitor).</li>
            </ul>
          </div>
          <div>
            <h4>Fluoroquinolones (e.g., Ofloxacin)</h4>
            <ul class="tight">
              <li>Use only if alternatives unsuitable (MHRA). Risks: tendonitis/rupture, neuropathy, CNS, dysglycaemia, QT, aortic aneurysm/dissection, valve regurgitation.</li>
              <li>Avoid with corticosteroids; caution in &gt;60 y and seizure risk.</li>
            </ul>
          </div>
        </div>
        <details style="margin-top:10px">
          <summary>Metronidazole notes</summary>
          <ul class="tight" style="margin-top:8px">
            <li>Warn possible <em>disulfiram‑like</em> reaction with alcohol (avoid during treatment and for ≥48 h after).</li>
            <li>Interactions: warfarin (↑INR), lithium (toxicity risk), ciclosporin (↑levels), 5‑FU (↑toxicity).</li>
          </ul>
        </details>
      </article>
    </section>

    <div class="footer">
      <small>Designed for fast, single‑page use at point of care. Use clinical judgement and local microbiology policies.</small>
      <small>Source: NICE Clinical Knowledge Summaries — Urethritis (male), last revised May 2024. © Respective owners.</small>
    </div>
  </main>

  <div class="floating">
    <button class="btn" onclick="scrollTo({top:0,behavior:'smooth'})" title="Back to top">
      ↑ Top
    </button>
  </div>

  <script>
    // Theme toggle with localStorage
    const root = document.documentElement;
    const btn = document.getElementById('themeToggle');
    function applyTheme(mode){
      if(mode === 'light'){ root.classList.add('light'); btn.setAttribute('aria-pressed','true'); }
      else { root.classList.remove('light'); btn.setAttribute('aria-pressed','false'); }
    }
    const saved = localStorage.getItem('urethritis-theme');
    applyTheme(saved || 'dark');
    btn.addEventListener('click', () => {
      const nowLight = !root.classList.contains('light');
      applyTheme(nowLight ? 'light' : 'dark');
      localStorage.setItem('urethritis-theme', nowLight ? 'light' : 'dark');
    });

    // Keyboard shortcuts
    // d = toggle theme, p = print, t = top
    window.addEventListener('keydown', (e) => {
      if (e.target.closest('input, textarea, [contenteditable="true"]')) return;
      if (e.key.toLowerCase() === 'd') btn.click();
      if (e.key.toLowerCase() === 'p') window.print();
      if (e.key.toLowerCase() === 't') scrollTo({top:0,behavior:'smooth'});
    });
  </script>
</body>
</html>